Following our analysis in February 2021 on the utilization of PMP Gateway within multiple states, we are examining the effectiveness of PMP Gateway across several metrics to understand its impacts.
Opioid abuse continues to be an important and growing public health concern. Electronic Prescription Drug Monitoring Programs (PDMPs) have been implemented by states across the country to address this issue. These are tools designed to curb prescription misuse and diversion by allowing prescribers to access a patient’s controlled-substance prescription history before writing a prescription or dispensing an opioid prescription. These data repositories are typically accessed through a web portal and this process can take up to 52 clicks and four minutes for a single report. The in-workflow integration of Appriss Health’s PMP Gateway is an enormous simplification of this process, requiring only a single click and 1-3 seconds. Appriss Health works with over 500 electronic health record (EHR) vendors to create an embedded PDMP report. This includes major physician EHR companies like Epic, as well as software for pharmacy workflow.
Accessing PDMP data via a web portal takes up to 52 clicks and four minutes; with Appriss Health’s in-workflow integration, it takes as little as one click and 1-3 seconds.
The ability to view a patient’s history of controlled-substance dispensations at critical moments across the continuum of care should result in more optimal prescribing. In this paper, we examine outcomes associated with the use of PMP Gateway in eight states that have rolled out the solution statewide. Overall, the outcomes indicate positive trends associated with a reduction in the prescribing of opioids.
The findings showed generally positive results associated with PMP Gateway implementation across key outcomes.
Opioid dispensations decreased on average by 15.6% and did so at a rate that was 113% faster during the two-year period following implementation (Figure 1). This equated to 1,586 fewer opioid dispensations per day, on average, for each state during this period (p < 0.0001, r-squared = 0.56), as shown in Figure 2.
The research discussed in this paper was conducted with the intent of confirming what other research has shown, but also going beyond that. PDMP implementation, when integrated directly into a provider’s or pharmacist’s workflow, certainly has an impact on prescribing habits. We evaluated this impact by conducting a meta-analysis of changes in PDMP prescribing patterns in eight states with sufficient data prior to and post PMP Gateway rollout (that is, a period of approximately two years before and after). The choice for this approach was twofold.